Burrage Capital Management LLC 13F Holdings · last filed Q2 2021
Burrage Capital Management LLC reported 22 securities worth $99.74M in its SEC 13F filing for Q2 2021 (period ended 2021-06-30). Top holdings: BCRX (13.71%), NTLA (10.33%), EPZM (6.97%). Among its top 25 positions this quarter: 3 new, 3 added, 2 trimmed, 3 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BCRX | BIOCRYST PHARMACEUTICALS INC | $13.7M | 13.71% | 864,916 | Hold |
| 2 | NTLA | INTELLIA THERAPEUTICS INC | $10.3M | 10.33% | 63,634 | Hold |
| 3 | EPZM | EPIZYME INC | $7.0M | 6.97% | 836,802 | Added |
| 4 | EPIX | ESSA PHARMA INC | $6.8M | 6.80% | 237,442 | Hold |
| 5 | NEO | NEOGENOMICS INC | $6.7M | 6.70% | 147,921 | Hold |
| 6 | MEIP | MEI PHARMA INC | $6.6M | 6.66% | 2.3M | Hold |
| 7 | CRNX | CRINETICS PHARMACEUTICALS IN | $5.6M | 5.57% | 294,620 | Added |
| 8 | CYTK | CYTOKINETICS INC | $4.8M | 4.85% | 244,673 | Hold |
| 9 | FOLD | AMICUS THERAPEUTICS INC | $4.8M | 4.83% | 500,000 | New |
| 10 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $4.2M | 4.25% | 150,000 | Hold |
| 11 | INZY | INOZYME PHARMA INC | $4.1M | 4.14% | 242,517 | Added |
| 12 | YMAB | Y-MABS THERAPEUTICS INC | $3.9M | 3.88% | 114,454 | Hold |
| 13 | MIRM | MIRUM PHARMACEUTICALS INC | $3.6M | 3.57% | 205,866 | Hold |
| 14 | ADCT | ADC THERAPEUTICS SA | $3.0M | 3.05% | 124,875 | Hold |
| 15 | VSTM | VERASTEM INC | $2.9M | 2.88% | 705,585 | New |
| 16 | MRUS | MERUS N V | $2.8M | 2.76% | 130,683 | Hold |
| 17 | GERN | GERON CORP | $2.7M | 2.70% | 1.9M | Hold |
| 18 | TECX | AVROBIO INC | $2.2M | 2.18% | 244,920 | Hold |
| 19 | RVMD | REVOLUTION MEDICINES INC | $1.6M | 1.59% | 50,000 | New |
| 20 | BDTX | BLACK DIAMOND THERAPEUTICS I | $1.3M | 1.35% | 110,447 | Hold |
| 21 | GTHX | G1 THERAPEUTICS INC | $1.0M | 1.05% | 47,708 | Trimmed |
| 22 | TPTX | TURNING POINT THERAPEUTICS I | $169,000 | 0.17% | 2,164 | Trimmed |
| 23 | APLS | APELLIS PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
| 24 | CARA | CARA THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 25 | FULC | FULCRUM THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2021-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR